Tag: pharmaceuticals
-
Patent Awarded for Whooping Cough Antibodies
An experimental treatment for pertussis, also known as whooping cough, using engineered humanized antibodies received a patent in the U.S.
-
Stem Cell Therapy Company Formed, Staked to $225M
A pharmaceutical company and health care venture investor are forming BlueRock Therapeutics, a biotechnology enterprise to design regenerative medicine treatments with stem cells.
-
Engineered T-Cells Tested on Metastatic Cancer
An individual with lung cancer tumors that spread from the colon had the tumors reduced in size after a single treatment of modified cancer-killing immune system cells.
-
Synthetic Insulin-Producing Cells Designed, Tested
Synthetic beta cells, like natural cells in the pancreas, were shown in tests with lab mice to sense glucose levels in the blood and produce insulin.
-
Start-Up Reprogramming Stem Cells to Treat Heart Failure
A new enterprise, spun-off from the Gladstone Institutes in San Francisco, plans to regenerate heart muscle from other cells to treat heart failure.
-
Ostrich Antibodies to Fight Resistant Infections
A biotechnology company developing antibodies grown in ostrich eggs is partnering with a Boston hospital to test a new treatment for Clostridium difficile, or C. difficile, a stubborn infection, increasingly resistant to antibiotics, and often contracted in hospitals.
-
High Leukemia Remissions Reported for Engineered T-Cells
First results from an international clinical trial of engineered immune system cells to treat leukemia in children show high rates of remission, but also many severe adverse effects.
-
Biotech to Earn Up to $1 Billion from Synthetic Peptides
A biotechnology enterprise designing synthetic peptides to treat a range of diseases could gain up to $1 billion or more in a licensing deal with the pharmaceutical company AstraZeneca.
-
Stem Cell Therapy Shows Early Results with Multiple Myeloma
First results from an early clinical trial show some patients with multiple myeloma receiving replacement blood-forming stem cells achieved at least a partial response and did not suffer severe adverse effects.
-
Room-Temperature Vaccine Storage Techniques Devised
Vaccines against viral diseases today need to be kept refrigerated to prevent spoilage, which raises costs and often prevents their widespread use in many developing regions. A team of materials scientists at Ecole polytechnique fédérale de Lausanne in Switzerland, or EPFL, proposes methods for storing vaccines without refrigeration for many days.